These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51 related articles for article (PubMed ID: 33852927)
1. Transcultural assessment of quality of life in patients with vitiligo. Hans A; Reddy KA; Black SM; Thomas J; Martinez-Luna O; McKesey J; Hynan LS; Pandya AG J Am Acad Dermatol; 2022 May; 86(5):1114-1116. PubMed ID: 33852927 [No Abstract] [Full Text] [Related]
2. Assessing the trends of outcome measures and quality of life instruments in vitiligo: A systematic review. Maghfour J; Shoukfeh R; Hamzavi IH; Ezzedine K; Mohammad TF J Eur Acad Dermatol Venereol; 2023 Nov; 37(11):2270-2272. PubMed ID: 37566732 [No Abstract] [Full Text] [Related]
3. Use of camouflage in vitiligo: A cross-sectional survey. Poondru S; Kundu RV J Cosmet Dermatol; 2023 Dec; 22(12):3524-3526. PubMed ID: 37352455 [No Abstract] [Full Text] [Related]
4. Psychological comorbidities of vitiligo: a retrospective cross-sectional analysis in an urban population. Montgomery SN; Syder N; Barajas G; Elbuluk N Arch Dermatol Res; 2023 Dec; 316(1):14. PubMed ID: 38047925 [No Abstract] [Full Text] [Related]
5. A pledge for a better care and consideration of patients with vitiligo. Passeron T Br J Dermatol; 2024 Apr; 190(5):614-615. PubMed ID: 38513637 [No Abstract] [Full Text] [Related]
6. Vitiligo, it was about time! Passeron T J Eur Acad Dermatol Venereol; 2023 Nov; 37(11):2155-2156. PubMed ID: 37877766 [No Abstract] [Full Text] [Related]
9. Views on vitiligo disease course and treatment among people living with vitiligo and healthcare providers worldwide. Br J Dermatol; 2023 Oct; 189(5):e94. PubMed ID: 37879743 [No Abstract] [Full Text] [Related]
10. The real-life efficacy of methotrexate in vitiligo: A retrospective study and literature review. Speeckaert R; van Geel N J Eur Acad Dermatol Venereol; 2023 Nov; 37(11):2267-2269. PubMed ID: 37571807 [No Abstract] [Full Text] [Related]
11. Demographics of Vitiligo in the DataDerm Database. Cunningham KN; Alsukait S; Learned C; Deverapalli S; Aninos A; Rosmarin D J Cutan Med Surg; 2023; 27(5):529-530. PubMed ID: 37522738 [No Abstract] [Full Text] [Related]
12. Global recommendations for vitiligo management. Ring J J Eur Acad Dermatol Venereol; 2023 Nov; 37(11):2157-2158. PubMed ID: 37877761 [No Abstract] [Full Text] [Related]
13. Understanding the impacts of vitiligo to provide better care. Meurant JM J Eur Acad Dermatol Venereol; 2023 Nov; 37(11):2161-2162. PubMed ID: 37877765 [No Abstract] [Full Text] [Related]
14. Commentary on vitiligo patient population and disease burden in France: VIOLIN Study results from the CONSTANCES cohort. Pandya AG J Eur Acad Dermatol Venereol; 2023 Nov; 37(11):2159-2160. PubMed ID: 37877764 [No Abstract] [Full Text] [Related]
15. Microneedling as an Adjuvant to Local Therapies for Vitiligo: A Systematic Review and Meta-Analysis. Joseph-Michel Bailey A; Oi-Yee Li H; Zheng D; Glassman SJ; Tan MG Dermatol Surg; 2021 Sep; 47(9):1314-1316. PubMed ID: 33927094 [No Abstract] [Full Text] [Related]
16. Decreased circulatory levels of Vitamin D in Vitiligo: a meta-analysis. Varikasuvu SR; Aloori S; Varshney S; Bhongir AV An Bras Dermatol; 2021; 96(3):284-294. PubMed ID: 33863565 [TBL] [Abstract][Full Text] [Related]
17. Oral gliadin-protected superoxide dismutase in addition to phototherapy for treating non-segmental vitiligo: A 24-week prospective randomized placebo-controlled study. Fontas E; Montaudié H; Passeron T J Eur Acad Dermatol Venereol; 2021 Aug; 35(8):1725-1729. PubMed ID: 33931900 [TBL] [Abstract][Full Text] [Related]
18. Targeting Innate Immunity to Combat Cutaneous Stress: The Vitiligo Perspective. Boniface K; Passeron T; Seneschal J; Tulic MK Front Immunol; 2021; 12():613056. PubMed ID: 33936032 [TBL] [Abstract][Full Text] [Related]